Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Windtree Therapeutics Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 19 | 26 | +7 |
| Shares | 1.46M | 1.71M | +244.9K (+16.7%) |
| Value | $3.02M | $2.72M | −$293.2K (−9.7%) |
New holders (8)
Institutions that held Windtree Therapeutics Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 136,700 | $219.0K | 0.00% |
| Citadel Advisors LLC | 40,996 | $66.0K | 0.00% |
| Rockwood Wealth Management, LLC | 13,601 | $21.8K | 0.01% |
| Dimensional Fund Advisors LP | 12,906 | $21.0K | 0.00% |
| Millennium Management LLC | 12,773 | $21.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 1,200 | $1.93K | 0.00% |
| Tower Research Capital LLC (TRC) | 472 | $1.00K | 0.00% |
| Blue Bell Private Wealth Management, LLC | 5 | $0 | 0.00% |
Sold out (1)
Institutions that held Windtree Therapeutics Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Northwestern Mutual Wealth Management Co | 5,200 | $11.0K |